EIGR

Eiger BioPharmaceuticals, Inc.
EIGR

Overview Fund Activity
Delisted

EIGR was delisted on the 10th of April, 2024.

Back to rankings

81 hedge funds and large institutions have $28.9M invested in Eiger BioPharmaceuticals, Inc. in 2022 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 28 increasing their positions, 23 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
81
Holders Change
-11
Holders Change %
-11.96%
% of All Funds
1.31%
Holding in Top 10
–
Holding in Top 10 Change
-6
Holding in Top 10 Change %
-100%
% of All Funds
–
New
17
Increased
28
Reduced
23
Closed
26
Calls
$303K
Puts
$48K
Net Calls
+$255K
Net Calls Change
-$1.06M

Top Buyers

1
Barclays
1
Barclays
United Kingdom
$1.91M
2
Millennium Management
2
Millennium Management
New York
$905K
3
Acadian Asset Management
3
Acadian Asset Management
Massachusetts
$578K
4
AQR Capital Management
4
AQR Capital Management
Connecticut
$573K
5
Morgan Stanley
5
Morgan Stanley
New York
$978K

Top Sellers

1
Adage Capital Partners
1
Adage Capital Partners
Massachusetts
$0
2
IVM
2
InterWest Venture Management
California
$0
3
BBA
3
Baker Bros. Advisors
New York
$0
4
CA
4
CHI Advisors
New York
$0
5
ACM
5
Altium Capital Management
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Mirae Asset Global Investments
101
Mirae Asset Global Investments
South Korea
– -$115K -511 Closed
FRM
102
Fox Run Management
Connecticut
– -$93K -412 Closed
DTL
103
Dynamic Technology Lab
Singapore
– -$81K -358 Closed
CM
104
Caption Management
Oklahoma
– -$74K -325 Closed
MLICM
105
Metropolitan Life Insurance Company (MetLife)
New York
– -$17.5K -78 Closed
AIM
106
Axiom Investment Management
New York
– -$8K -33 Closed
1 2 3 4
5